In utero hematopoietic cell transplantation: What are the important questions?

William H. Peranteau, Satoshi Hayashi, Heung Bae Kim, Aimen F. Shaaban, Alan W. Flake*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


The treatment of congenital hematologic disorders before birth by in utero hematopoietic stem cell transplantation remains a challenging goal. Although success has been achieved in X-linked severe combined immunodeficiency, the approach has failed in all other disorders attempted thus far. In this review, we examine relevant experimental data from the perspective of an analysis of why failure has occurred. We will also attempt to pose the important questions that will need to be answered prior to further clinical attempts to treat most target disorders by this approach.

Original languageEnglish (US)
Pages (from-to)9-12
Number of pages4
JournalFetal Diagnosis and Therapy
Issue number1
StatePublished - Jan 1 2004


  • Fetal therapy
  • Hematopoietic stem cell
  • In utero stem cell transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology


Dive into the research topics of 'In utero hematopoietic cell transplantation: What are the important questions?'. Together they form a unique fingerprint.

Cite this